aod9604 fda approved AOD-9604 - Peptide for Fat Loss & Body Composition Is AOD 9604 (Anti-Obesity Drug)

published data in Endocrinology showing the peptide's ability to reduce adipose tissue in ob/ob mice by 50% over 19 days without affecting lean mass or circulating IGF-1 [1]

In rodent knockout models where beta-3 adrenergic receptors were removed, the lipolytic response to AOD 9604 was eliminated, confirming the receptor-specific mechanism

Polar Peptides supplies high-purity research products, peptide blends, laboratory-use materials, and advanced analytical compounds manufactured with quality, consistency, and secure packaging in mind

Supporting Metabolic Health in Type 2 Diabetes Metabolic health is the cornerstone of long-term wellness, and insulin sensitivity is a key player